BCM
MTEM

Bayesian Capital Management’s Molecular Templates, Inc. MTEM Stock Holding History

Bayesian Capital Management’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-136
Closed -$10K – 581
2016
Q1 		$10K Buy
+136
New +$8.03K 0.01% 341

Other funds holding MTEM

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bayesian Capital Management's MTEM Position: Q2 2016 in Review

Bayesian Capital Management sold out of Molecular Templates, Inc. (MTEM) in Q2 2016, closing a stake of 136 shares — an estimated $10K sold.

Bayesian Capital Management first reported a position in MTEM in Q1 2016 and held it in 1 quarter. The position peaked at $10K in Q1 2016. 60 funds tracked by Wall St. Rank hold MTEM as of Q2 2016.

  • Bayesian Capital Management reported no remaining Molecular Templates, Inc. position as of Q2 2016 after selling out during the quarter.
  • Bayesian Capital Management sold 136 Molecular Templates, Inc. shares in Q2 2016, an estimated $10K.
  • Bayesian Capital Management first reported a position in Molecular Templates, Inc. in Q1 2016 and held it in 1 quarter.
  • Bayesian Capital Management's Molecular Templates, Inc. position peaked at $10K in Q1 2016.
  • 60 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2016.

Based on Bayesian Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.